YONGFANG HU | Medicine and Health Sciences | Best Researcher Award

Published on 23/04/202523/04/2025 by Research Hypothesis

YONGFANG HU | Medicine and Health Sciences | Best Researcher Award

Assoc. Prof. Dr YONGFANG HU, Beijing Tsinghua Changgung Hospital, China

Assoc. Prof. Dr. Yongfang Hu is a distinguished clinical pharmacist and academic with over three decades of impactful service in pharmacy and pharmacology. 📚🧬 She earned her degrees from Lanzhou University and Central South University, focusing on pharmacology and clinical pharmacology. 💊 She has held prominent roles at leading institutions such as Lanzhou University, Peking University Third Hospital, and Tsinghua Changgung Hospital. 🌟 Her pioneering research covers pharmacogenomics, organ transplant pharmacotherapy, and elderly care medication. 🧠💉 A highly respected scholar, she has authored influential publications and led studies on multidrug-resistant infections and personalized medicine. 📈🧫 Dr. Hu’s commitment to advancing safe, effective drug therapies makes her a standout candidate for the Best Researcher Award. 🌐🥇

Publication Profile

Orcid

Education

Dr. Yongfang Hu’s academic journey began with a Bachelor’s Degree in Pharmacy from the School of Pharmacy, Lanzhou University (1988). 🎓💊 She further pursued a Master’s Degree in Pharmacology from the same institution in 2000, deepening her understanding of drug mechanisms and therapeutic strategies. 🔬📘 To solidify her expertise in clinical applications, she earned a Doctorate in Clinical Pharmacology from the Institute of Clinical Pharmacology, Central South University (2005). 🧬📖 Her academic training spans fundamental pharmacy, experimental pharmacology, and patient-centered pharmacotherapy, laying a strong foundation for her research in genomics, drug therapy, and personalized medicine. 🧠🧪 Each milestone in her educational path reflects her lifelong dedication to pharmacological sciences and clinical excellence. 🏅📚

Experience

From 1988 to 2002, Dr. Hu served as a Deputy Chief Pharmacist and Associate Professor at the Second Affiliated Hospital of Lanzhou University. 🏥📘 She later joined Peking University Third Hospital (2005–2014) as a Chief Pharmacist and Associate Professor, advancing clinical pharmacy services and academic programs. 🧪📈 Between 2014 and 2015, she led the Pharmacy Department at Tsinghua Changgung Hospital, and since 2015, she continues there as a Chief Pharmacist and Associate Professor of Clinical Pharmacy. 🧬🏥 Her clinical and academic leadership across top Chinese institutions showcases her expertise in implementing advanced pharmaceutical care and mentoring future pharmacists. 💡🎓

Awards and Honors

Dr. Hu has received multiple recognitions for her excellence in pharmacy and research. 🏆 In her tenure, she has been honored with Institutional Excellence Awards for Clinical Pharmacy Innovation and Outstanding Research Contributions at Peking University Third Hospital and Tsinghua Changgung Hospital. 🎖️ She has been invited to serve on editorial boards and academic review committees, reflecting her standing in the scientific community. 📚👩‍⚕️ Her extensive work on drug genomics and personalized medicine has earned her accolades at national pharmacology conferences. 🧬🌟 These honors signify her continuous impact on both patient care and the broader medical research landscape. 🧠🏅

Research Focus

Dr. Hu’s research primarily focuses on the genomics of organ transplantation drugs and pharmacogenomics of thromboembolic diseases. 🧬🫀 She explores how genetic variations influence drug responses, aiming to tailor therapies for optimal patient outcomes. 🧠💊 She also delves into drug therapies for infectious diseases, including strategies to combat multidrug-resistant organisms, particularly in transplant patients. 🧫🛡️ Her work extends to cardiovascular pharmacotherapy and medication optimization in the elderly population, tackling polypharmacy and age-related metabolic changes. 👵❤️ Through clinical studies and predictive modeling, Dr. Hu drives personalized medicine in real-world settings. 📊🔍 Her interdisciplinary approach bridges pharmacology, genomics, and patient care. 🌐🔗

Publication Top Notes

Epidemiology and Risk Prediction Model of Multidrug-Resistant Organism Infections After Liver Transplant Recipients: A Single-Center Cohort Study 🧫🧬

Tawanda Chivese | Medicine and Health Sciences | Best Researcher Award

Published on 22/04/202522/04/2025 by Research Hypothesis

Tawanda Chivese | Medicine and Health Sciences | Best Researcher Award

Assist. Prof. Dr Tawanda Chivese, University of Washington Tacoma, United States

Assist. Prof. Dr. Tawanda Chivese is an accomplished epidemiologist specializing in clinical epidemiology. With a Ph.D. in Medicine from the University of Cape Town, and an MSc (cum laude) in Clinical Epidemiology from Stellenbosch University, Dr. Chivese has a strong foundation in advanced epidemiological methods, biostatistics, and global health. He is currently an Assistant Professor of Epidemiology at the University of Washington Tacoma, and an Extraordinary Senior Lecturer at Stellenbosch University. Over his career, Dr. Chivese has led impactful international research on diabetes, gestational diabetes, cardiometabolic diseases, and mental health outcomes. His work has been published in high-impact peer-reviewed journals, and he actively contributes as a journal reviewer and editorial board member. Dr. Chivese’s commitment to academic excellence, mentorship, and research collaboration marks him as a distinguished researcher with significant contributions to global public health.

Publication Profile

Orcid

Education

Dr. Tawanda Chivese holds a Ph.D. in Medicine (2021) from the University of Cape Town, where he investigated the long-term effects of hyperglycemia in pregnancy on offspring obesity and cardiovascular risk. He earned his MSc Clinical Epidemiology (cum laude, 2014) from Stellenbosch University, completing advanced coursework in epidemiology, biostatistics, and systematic reviews. His Master’s research focused on cigarette smoking and Crohn’s Disease phenotypes. Earlier, he completed a Bachelor of Science (Honours) in Nursing Science (2006) from the University of Zimbabwe, developing a strong clinical foundation. He has supplemented his formal education with specialized training in systematic reviews, digital skills, blended learning, biomedical ethics, and diagnostic test accuracy through global institutions like the University of Birmingham and the University of Oxford. Dr. Chivese’s comprehensive education underpins his expertise in clinical epidemiology and global health research.

Experience

Dr. Chivese is currently an Assistant Professor (tenure-track) at the University of Washington Tacoma (2024-present), leading epidemiology and public health teaching, collaborative research on gestational diabetes, and supervising student research. Previously, he served as Assistant Professor at Qatar University (2019-2024), where he coordinated key courses, redesigned epidemiology curricula, and mentored over 100 student researchers, many winning top awards. He fostered collaborations with the Qatar Ministry of Public Health and Qatar Biobank. Concurrently, Dr. Chivese has held honorary positions at Stellenbosch University and the South African Medical Research Council since 2016. His experience combines academic leadership, innovative teaching, curriculum development, large-scale collaborative research, and scholarly publication. His global impact is evidenced by partnerships across Africa, the Middle East, and the U.S., positioning him as a leading figure in global clinical epidemiology.

Awards and Honors

Dr. Tawanda Chivese’s dedication to excellence has earned him multiple accolades. He received consistent teaching excellence awards during his tenure at Qatar University and awards for supervising the best undergraduate research projects. His leadership contributions to the Public Health Association of South Africa, serving on the executive board and as Vice Chairperson for a special interest group, underline his influence in public health leadership. His scholarly work has been recognized with prestigious grants, including funding from Qatar Foundation, Welcome Trust, and SAMRC/Newton Fund. In addition, he has been selected as an editorial board member for BMC Public Health and frequently reviews for top-tier journals like The Lancet and PLOS Medicine. These honors reflect his outstanding achievements in research, teaching, mentorship, and service to the academic and public health communities.

Research Focus

Dr. Chivese’s research primarily focuses on the intersection of metabolic and mental health diseases, particularly diabetes, cardiovascular risks, and cognitive outcomes post-gestational diabetes. He specializes in clinical epidemiology, meta-analysis, and diagnostic accuracy studies. His recent projects include investigating the developmental origins of autism spectrum disorders, the role of poor glycemic control in cognitive dysfunction, and refining meta-analysis methods for improved evidence synthesis. He also leads collaborative studies on lifestyle interventions to prevent cardiometabolic diseases in high-risk populations. His work aims to uncover critical determinants of chronic disease progression and provide actionable public health interventions. Dr. Chivese’s research approach is interdisciplinary, combining clinical insight, advanced statistical methods, and global collaboration to address complex health challenges in both low- and high-income settings.

Publication Top Notes

Prevalence of unintended pregnancy in the MENA region: a systematic review and meta-analysis

Infoveillance of COVID-19 Infections in Dentistry Using Platform X: Descriptive Study

Comparative Efficacy of Subcutaneous Versus Intravenous Interleukin 12/23 Inhibitors for the Remission of Moderate to Severe Crohn’s Disease: A Systematic Review and Meta-Analysis

Cross-cultural adaptation: South African Gestational Diabetes Mellitus Knowledge Questionnaire

Prevalence and factors associated with falls in older adults in a Middle Eastern population: a retrospective cross-sectional study

Estimates of the prevalence of male circumcision in sub-Saharan Africa from 2010–2023—A systematic review and meta-analysis

Integrated health system intervention aimed at reducing type 2 diabetes risk in women after gestational diabetes in South Africa (IINDIAGO): a randomised controlled trial protocol

Yong Ahn | Medicine and Health Sciences | Best Researcher Award

Published on 22/04/202522/04/2025 by Research Hypothesis

Yong Ahn | Medicine and Health Sciences | Best Researcher Award

Prof. Dr Yong Ahn, Kyung Hee University Hospital, Kyung Hee University College of Medicine at Gangdong, Kyung Hee University College of Medicine, South Korea

Prof. Dr. Yong Ahn is a globally recognized leader in minimally invasive spine surgery. Having earned his MD and PhD from Seoul National University School of Medicine, Dr. Ahn has devoted his career to advancing surgical techniques that minimize patient recovery time and improve outcomes. Currently serving as President of Wooridul Spine Hospital, he also heads the Department of Neurosurgery at Armed Forces Chungpyung Hospital. Dr. Ahn’s distinguished contributions are acknowledged worldwide, as reflected in his inclusion in MARQUIS Who’s Who and receipt of the Albert Nelson Marquis Lifetime Achievement Award. He holds pivotal roles in several spine surgery societies, chairs editorial boards for prestigious journals, and actively shapes the field through extensive research and publication. His dedication and innovations make him an exemplary candidate for the Best Researcher Award.

Publication Profile

Orcid

Education

Prof. Dr. Yong Ahn completed both his MD and PhD at the prestigious Seoul National University School of Medicine in Korea. Beyond his medical degrees, he expanded his expertise internationally, becoming a Fellow of the American Board of Minimally Invasive Spinal Surgery and the Royal College of Physicians and Surgeons. His educational background is marked by a combination of rigorous academic training and a forward-looking vision for medical innovation. Dr. Ahn’s academic pursuits laid a strong foundation for his pioneering work in minimally invasive techniques and spinal endoscopy, fields in which he would later become a leading authority. His commitment to lifelong learning and professional development exemplifies the values necessary for outstanding contributions to medical science.

Experience

Dr. Yong Ahn has had an illustrious career, marked by leadership and innovation in spine surgery. He currently serves as the President of Wooridul Spine Hospital and as Head of Neurosurgery at Armed Forces Chungpyung Hospital. Dr. Ahn also plays critical roles in academic societies, including being Chairperson of the Korean Endoscopic Spine Surgery Society and Scientific Manager of the Korean Minimally Invasive Spine Surgery Society. His expertise extends to national policy, where he serves on the Inter-Ministerial Evaluation Committee for national R&D projects. As Editor-in-Chief of JMISST-Video and an editorial board member of European Spine Journal, Biomed Research International, and PLOS One, he influences scientific communication globally. His experience is distinguished by a balance between surgical excellence, academic leadership, and contributions to national and international healthcare systems.

Awards and Honors

Prof. Dr. Yong Ahn’s outstanding achievements have been recognized through numerous prestigious awards. He received the Gachon University President’s Special Award for Research Excellence in 2020, honoring his significant research contributions. In 2018, he was awarded the Albert Nelson Marquis Lifetime Achievement Award, further confirming his global impact. Dr. Ahn’s inclusion in the MARQUIS Who’s Who reflects his longstanding influence and excellence in the field of spine surgery. His leadership positions within various professional societies and editorial roles also signify peer recognition of his professional authority and contributions. Each award not only celebrates his past accomplishments but also highlights his continuing commitment to advancing medical science and patient care.

Research Focus

Dr. Yong Ahn’s research focuses primarily on minimally invasive spine surgery and endoscopic procedures. He is a pioneer in developing techniques that allow complex spinal conditions to be treated with reduced surgical trauma, faster recovery, and improved patient outcomes. His studies address critical topics such as the learning curve associated with minimally invasive techniques, surgical complications like dural tears, and innovations in endoscopic decompression procedures. Dr. Ahn’s research bridges clinical practice and technological advancement, making significant strides in the refinement of surgical methods. As an editor and author of core textbooks in his field, he also contributes to education and knowledge dissemination. His commitment to evidence-based practice ensures that his research directly benefits both the scientific community and patients worldwide.

Publication Top Notes

Magnetic Resonance Imaging Predictors of Surgical Difficulty in Transforaminal Endoscopic Lumbar Discectomy for Far-Lateral Disc Herniation Under Local Anesthesia

A Commentary on “Full-Endoscopic Resection of a Lumbar Intradural Tumor (Schwannoma): Video Case Report and Description of the Surgical Technique”

Transforaminal Endoscopic Lumbar Foraminotomy for Iatrogenic Foraminal Stenosis Following Vertebroplasty

Access Pain During Transforaminal Endoscopic Lumbar Discectomy for Foraminal or Extraforaminal Disc Herniation

Access Pain during Transforaminal Endoscopic Lumbar Discec-Tomy for Foraminal or Extraforaminal Disc Herniation

Learning Curve for Endoscopic Transsphenoidal Surgery: A Systematic Review and Meta-Analysis

Bruno Songel Sanchis | Medicine and Health Sciences | Best Review Paper Award

Published on 21/04/202521/04/2025 by Research Hypothesis

Bruno Songel Sanchis | Medicine and Health Sciences | Best Review Paper Award

Mr Bruno Songel Sanchis, Hospital clínico San Carlos, Spain

Mr. Bruno Songel Sanchis 🎻👓 is a versatile professional with dual expertise in music and vision sciences. Holding a Master’s in Optometry and Vision Sciences from the Complutense University of Madrid 🎓, and a degree in Optics and Optometry from the University of Valencia, he seamlessly combines clinical acumen with research innovation. His extensive clinical experience spans Hospital Clínico San Carlos and Fundación Salud Visual, focusing on cutting-edge myopia control, glaucoma diagnostics, and AI integration in ophthalmology 🤖🧠. Beyond clinics, Bruno’s passion for community service is evident through his impactful volunteer roles and outreach projects 🫶. A talented cellist 🎶 and a committed scientist, he bridges the gap between art and science with grace and dedication. His systematic review on ocular manifestations in IBD showcases his research depth 📄📊. A creative thinker and empathetic clinician, Bruno is a promising contender for the Best Review Paper Award 🥇🧬.

Publication Profile

Orcid

Education

Bruno Songel Sanchis has a rich and interdisciplinary educational background 🎓✨. He earned his Professional Degree in Music (Violoncello) from the Professional Music Conservatory of Valencia 🎻, showcasing his artistic talents. He later pursued a Scientific Baccalaureate at San José de Calasanz High School 🧪📘. Bruno’s scientific journey led him to the University of Valencia, where he obtained his Degree in Optics and Optometry 👁️📐. Committed to advancing vision care, he continued with a Master’s Degree in Optometry and Vision Sciences at the prestigious Complutense University of Madrid 👓🔬. He’s currently engaged in Project Efficiency Boost (2025–present), enhancing clinical productivity through AI and innovation 🚀🤖. His academic versatility reflects both analytical rigor and creativity, a rare blend that empowers his impactful work in clinical practice and scientific research 🧠📚.

Experience

Bruno has extensive hands-on experience in both clinical and research settings 🏥🔬. He served as a Clinical Optometrist at Hospital Clínico San Carlos (Madrid), rotating across subspecialties like myopia, retina, glaucoma, and cataracts 👁️💉. He contributed to pivotal research on myopia control with Atropine and later as a Clinical Research Technician at IdISSC, focused on the ‘LYDIA project’ developing AI diagnostic tools 🤖📊. His role as a Product Specialist marked a major milestone—implementing Europe’s first AI-powered ophthalmic imaging system at La Paz Hospital 🏥✨. Earlier, he worked at Óptica Universitaria and Alain Afflelou, gaining practical skills in optometry, sales, and customer care 🛠️🛍️. Bruno also holds a current role at Fundación Salud Visual (Funsavi), continuing his clinical contributions while mentoring others. These experiences shape him into a well-rounded professional with deep clinical knowledge, technical skills, and patient-centered care focus 👓🫶.

Awards and Honors

Bruno Songel Sanchis has garnered multiple honors for both creativity and scientific excellence 🏆📚. He won 1st prize in the UV Creative Outreach Project (2021) for innovative public science engagement 🎨💡. At the UVemprén Startup – Crea Awards, he secured 3rd position for his entrepreneurial vision in healthcare 🔬🚀. His musical talents earned him an Honorable Mention Diploma at an International Music Seminar, reflecting his multifaceted abilities 🎶🏅. He was also a Finalist in the MOTIVEM UV Awards, acknowledging his academic initiative and leadership 📘👏. As a Rapporteur at the SIYO 2022 Congress for Young Optometrists, he showcased his ability to bridge science and communication 🗣️📊. His certifications from the London School of Hygiene and Tropical Medicine in public health ophthalmology further validate his global competence in preventing blindness and tackling ocular diseases on an international level 🌍👁️.

Research Focus

Bruno Songel Sanchis’s research focuses on clinical optometry, ocular disease prevention, and artificial intelligence applications in ophthalmology 🧠👁️🤖. His major interests include myopia control, particularly using Atropine-based treatments, and early detection of age-related macular degeneration and glaucoma through AI-powered diagnostic systems 🧬📈. In collaboration with top-tier hospitals and research institutions, Bruno played a pivotal role in developing multi-diagnostic tools and conducting clinical trials on visual pathologies. His review on ocular extraintestinal manifestations in inflammatory bowel disease (IBD) offers critical insights into interdisciplinary patient care 📄🩺. A blend of practical clinical work and technical innovation defines his approach, with the goal of improving accessibility and effectiveness of vision care globally 🌐✨. His ongoing contributions to AI integration, coupled with community eye health initiatives, make him a forward-thinking optometrist and researcher committed to impactful, data-driven healthcare advancements 🩻📊.

Publication Top Notes

Analysis of the Incidence of Ocular Extraintestinal Manifestations in Inflammatory Bowel Disease Patients: A Systematic Review (2024)

Yu Pan | Medicine and Health Sciences | Young Scientist Award

Published on 16/04/202516/04/2025 by Research Hypothesis

Yu Pan | Medicine and Health Sciences | Young Scientist Award

Dr Yu Pan, Fujian Medical University Union Hospital, China

Dr. Yu Pan is a pioneering medical scientist and attending physician at the Department of General Surgery, Fujian Medical University Union Hospital, China. His groundbreaking research bridges immunotherapy and pancreatic cancer treatment, focusing on mechanisms shaping the tumor microenvironment and translating them into clinical applications. As the principal investigator of multiple prestigious grants, Dr. Pan leads a laboratory exploring mRNA vaccine development and immune regulation in pancreatic malignancies. With over a dozen high-impact publications, including in Nature Nanotechnology and JITC, his work is rapidly transforming the therapeutic landscape. An active mentor and educator, he has guided eight Master’s students, several of whom now pursue PhDs or hold clinical positions at top hospitals. Recognized for academic excellence and innovation, Dr. Pan exemplifies the qualities of a future leader in oncology and immunology. His contributions reflect a deep commitment to both science and society.

Publication Profile

Orcid

Education

Dr. Yu Pan is a dedicated medical professional with a strong academic background in Medical Sciences 🧠🔬. He began he journey in medicine at Anhui Medical University, China, where he earned he Bachelor’s degree between 2008 and 2013 🎓🇨🇳. He passion for advancing healthcare led he to pursue further studies at Fujian Medical University. From 2014 to 2017, he completed he Master’s degree in Medical Sciences, specializing in General Surgery 🏥🩺. Demonstrating exceptional commitment to surgical research and clinical excellence, Dr. Pan continued at the same university to obtain her Ph.D. in Medical Sciences from 2017 to 2020 🎓🔍. During her academic career, she gained extensive experience in surgical techniques, research methodologies, and patient care, contributing significantly to the field of general surgery 📚. He educational path reflects a continuous pursuit of knowledge and skill development, underscoring he role as a dedicated surgeon and researcher committed to medical innovation and patient well-being ❤️‍🩹.

Experience

Dr. Yu Pan is a dedicated surgical professional with extensive experience in clinical practice, teaching, and mentorship. From 2020 to 2022, Dr. Pan completed a surgical residency at the Department of Surgery, Fujian Medical University Union Hospital 🏥. Since 2022, he has served as a Staff Attending Physician in the Department of General Surgery 👨‍⚕️. Alongside his clinical duties, Dr. Pan has been actively involved in teaching as an Instructor for Clinical Skills Training Classes (2022–2024) at Fujian Medical University 🎓. He has also served as a thesis advisor for Master’s students since 2021, mentoring eight students in total. Five have graduated, with three pursuing PhDs and two now practicing at top institutions, including Jinhua Hospital and Fudan University Shanghai Cancer Center 🎯. His mentees have published in prestigious journals such as JITC, Functional Integrated Genomics, Frontiers in Pharmacology, and Cell Death & Disease 📚🔬, reflecting Dr. Pan’s strong academic impact.

Awards and Honors

Dr. Yu Pan is a highly accomplished medical researcher recognized for his consistent contributions to science and healthcare advancement 🧬🩺. He currently leads the 2025 Overseas Study Program for Young and Middle-Aged Medical Talents in Fujian Province 🌏✨. In 2023, he was selected for the Excellent Young Scholars Cultivation Project by Fujian Medical University Union Hospital (No. 2022XH025) 🧑‍🔬🏅. His expertise earned national recognition through the prestigious 2021 National Natural Science Foundation of China grant (No. 82103310) 🇨🇳🔍. That same year, he secured funding from the Natural Science Foundation of Fujian Province (No. 2021J01774) and played a pivotal role in the Joint Funds of the Scientific and Technological Innovation Program of Fujian Province (No. 2020Y9081) 💡🔬. Additionally, Dr. Pan led the 2020 Fujian Provincial Health Technology Project (No. 2020GGA029), further highlighting his dedication to medical research and innovation in the region.

Research Focus

Dr. Yu Pan’s research centers on pancreatic cancer and inflammatory-immune responses, with a strong emphasis on immune regulation, tumor microenvironment, and therapeutic targets 🧬🩸. His studies explore the role of Annexin A1, CD47-targeted therapies, and immune checkpoints in pancreatic disorders, especially pancreatic ductal adenocarcinoma (PDAC) and neuroendocrine neoplasms 🧫🧠. Through single-cell analysis, preclinical models, and clinical translation, Dr. Pan investigates how immune dynamics shape disease progression and treatment outcomes 🧪📊. His work contributes significantly to immunotherapy and precision medicine in gastrointestinal oncology, aiming to improve prognosis and treatment for patients with severe pancreatic conditions 💊🧠🧑‍⚕️.

Publication Top Notes

Annexin A1 regulates inflammatory-immune response and reduces pancreatic and extra- pancreatic injury during severe acute pancreatitis

Translating CD47-Targeted Therapy in Gastrointestinal Cancers: Insights from Preclinical to Clinical Studies

The prognostic and therapeutic value of the tumor microenvironment and immune checkpoints in pancreatic neuroendocrine neoplasms

Loss of Annexin A1 in macrophages restrains efferocytosis and remodels immune microenvironment in pancreatic cancer by activating the cGAS/STING pathway

High-dimensional single-cell analysis unveils distinct immune signatures of peripheral blood in patients with pancreatic ductal adenocarcinoma

Single-cell RNA sequencing revealed subclonal heterogeneity and gene signatures of gemcitabine sensitivity in pancreatic cancer

Prognostic value of preoperative enhanced computed tomography as a quantitative imaging biomarker in pancreatic cancer

Joseph M Pappachan | Medicine and Health Sciences | Best Researcher Award

Published on 16/04/202516/04/2025 by Research Hypothesis

Joseph M Pappachan | Medicine and Health Sciences | Best Researcher Award

Prof. Dr Joseph M Pappachan, Manchester Metropolitan University, United Kingdom

Prof. Dr. Joseph M. Pappachan is an internationally acclaimed endocrinologist and physician-scientist with profound contributions to metabolic and endocrine disorders. With over two decades of clinical, academic, and research experience, he currently serves at the Department of Endocrinology, Amrita Institute of Medical Sciences, India. His work bridges the gap between clinical practice and groundbreaking research, particularly in diabetes, obesity, metabolic syndrome, and endocrine hypertension. 📊 He has authored numerous high-impact publications and book chapters, and actively contributes to peer-reviewed journals as an editor and reviewer. Prof. Pappachan’s research is widely cited, reflecting his global influence in the field. 🌍 Known for his mentorship and academic leadership, he has trained many budding endocrinologists and researchers. His dedication to innovation and translational research has earned him multiple accolades and fellowships. 🧪 A dynamic scholar and clinician, Prof. Pappachan embodies excellence, integrity, and impact in the medical research community.

Publication Profile

Google Scholar

Education

Prof. Dr. Joseph M. Pappachan holds an MBBS degree from Government Medical College, Calicut, and completed his MD in Internal Medicine from Government Medical College, Trivandrum. 🏥 He further specialized in Endocrinology with a DM from the prestigious All India Institute of Medical Sciences (AIIMS), New Delhi. 📘 In pursuit of global medical standards, he earned Membership of the Royal College of Physicians (MRCP) in the UK and became a Fellow of the Royal College (FRCP) and Fellow of the American College of Endocrinology (FACE). 🎖️ Prof. Pappachan has also undergone advanced training in endocrinology and diabetes in the United Kingdom and Europe, further honing his expertise in clinical research and metabolic diseases. 🌍 His commitment to lifelong learning is evident in his pursuit of continuing medical education and participation in international research fellowships, solidifying his position as an educator and research innovator in the medical sciences.

Experience

With over 20 years in clinical practice and academic research, Prof. Pappachan has served in leading institutions in India and the UK. 🏥 He is currently a Senior Consultant and Professor at the Department of Endocrinology, Amrita Institute of Medical Sciences, Kochi. Previously, he held several academic positions in NHS hospitals and universities across the United Kingdom, where he actively participated in clinical trials and interdisciplinary research. 🌐 His professional journey includes experience in tertiary referral centers for complex endocrine and metabolic disorders. Prof. Pappachan is a sought-after speaker in national and international medical conferences and frequently leads CME programs for physicians. 🗣️ He also serves on the editorial boards of prominent journals and contributes significantly to peer-review processes. 🖋️ His extensive experience in patient care, medical education, and translational research makes him a respected authority in endocrinology worldwide.

Awards and Honors

Prof. Pappachan’s excellence in research has been recognized through numerous awards, fellowships, and international honors. 🏅 He has received the Fellowship of the Royal College of Physicians (FRCP), Fellowship of the American College of Endocrinology (FACE), and prestigious research grants for his work in metabolic disorders. 🎓 His research publications have garnered thousands of citations, and he ranks among the top Indian scientists in endocrinology. 📊 He has served as an expert panel member for international bodies and contributes to the development of clinical guidelines in diabetes and metabolic syndrome. 🌟 As an editorial board member and peer reviewer for several high-impact journals, his insight is valued across the medical research spectrum. 🧬 His outstanding contributions to patient care, research, and academic mentorship have earned him wide acclaim and nominations for top medical awards, making him a truly deserving candidate for the Best Researcher Award.

Research Focus

Prof. Pappachan’s research primarily centers on diabetes mellitus, obesity, metabolic syndrome, thyroid disorders, and hypertension, with a strong emphasis on the interplay between endocrine function and metabolic health. 🔍 His pioneering work investigates mechanisms of insulin resistance, neuroendocrine regulation, and cardiometabolic risk in various populations. His translational research explores clinical applications of novel diagnostic tools, therapeutic strategies, and biomarker discovery. 🧪 He has also examined sleep disorders and circadian rhythm disruptions in metabolic diseases and their implications for treatment outcomes. 🌙 His extensive publications focus on patient-centered interventions and the development of global clinical protocols. 📋 With multidisciplinary collaboration, Prof. Pappachan continues to advance understanding in precision medicine and evidence-based endocrinology, contributing significantly to the global discourse on metabolic and endocrine diseases. 🌐 His research is transformative, clinically relevant, and instrumental in shaping modern endocrine care.

Publication Top Notes

Omega-3 fatty acids: a comprehensive review of their role in health and disease

Diabetic cardiomyopathy: Pathophysiology, diagnostic evaluation and management

Diabetes mellitus and stroke: a clinical update

Cardiac autonomic neuropathy in diabetes mellitus: prevalence, risk factors and utility of corrected QT interval in the ECG for its diagnosis

High-dose cholecalciferol booster therapy is associated with a reduced risk of mortality in patients with COVID-19: a cross-sectional multi-centre observational study

Snakebite envenoming in Kerala, South India: clinical profile and factors involved in adverse outcomes

Esmaeil Mehraeen | Medicine and Health Sciences | Best Researcher Award

Published on 02/04/202502/04/2025 by Research Hypothesis

Esmaeil Mehraeen | Medicine and Health Sciences | Best Researcher Award

Dr Esmaeil Mehraeen, Khalkhal University of Medical Sciences, Iran

Dr. Esmaeil Mehraeen is an esteemed health informatics expert recognized for his contributions to medical research, particularly in health information management and digital health solutions. His research spans HIV self-management, telemedicine, AI in healthcare, and pandemic response strategies. A prolific author, he has published extensively on innovative healthcare technologies, ethical AI applications, and epidemiological assessments. His dedication to advancing medical informatics earned him recognition as the top researcher in Ardabil province in 2021. With a strong academic and executive background, he continues to shape the future of health informatics, making him an ideal candidate for the Best Researcher Award.

Publication Profile

Google Scholar

Education

Dr. Esmaeil Mehraeen is a dedicated expert in Health Information Management 📊🩺, earning his Ph.D. from Tehran University of Medical Sciences (2015-2018). His doctoral research focused on designing, developing, and evaluating a mobile and web-based intelligent self-management system for people living with HIV 📱💡. He previously completed an MSc in Medical Records Education (2010-2012) at the same university, where he explored information security in hospital information systems at Tehran and Shahid Beheshti Universities 🏥🔐. His academic journey began with a BSc in Medical Records (2005-2007) from Shahid Beheshti University of Medical Sciences 📑📚, laying the foundation for his expertise in health data management and security. With a strong background in digital health solutions and medical informatics, Dr. Mehraeen contributes to improving healthcare technology and patient self-management systems 🏥📲. His work bridges the gap between healthcare and innovative digital tools, ensuring secure and efficient health information management 🔍💻.

Experience

Dr. Esmaeil Mehraeen is a dedicated academic and researcher in medical sciences 🏥📚. He has served as a Faculty Member at Khalkhal University of Medical Sciences (2018-2024) 👨‍🏫 and previously held the same role at Zabol University of Medical Sciences (2012-2015) and Ardabil University of Medical Sciences (2016-2018) 🎓📖. His leadership roles include serving as Vice President of Education & Research at Khalkhal University (2019-2021) 📊🏛, where he contributed to advancing academic programs. Additionally, he was Student Manager (2018-2019) 🎓📋 and Head of the Scientometric Department (2018) 🔍📈. Dr. Mehraeen has been an active Research & Educational Council Member across various universities in Iran 📊🔬📚, fostering scientific collaboration and innovation. His extensive experience in medical education, research leadership, and scientometrics highlights his commitment to academic excellence and the advancement of healthcare sciences 📖🔬🏥.

Awards & Honors

Dr. Esmaeil Mehraeen is a distinguished researcher recognized as the Top Researcher in Ardabil Province (2021) 🏆🎖 for his outstanding contributions. His academic excellence began early, securing 1st place in the Ph.D. Entrance Exam (2015) 🥇📚 and being honored as an Exemplary Student in his MSc Program (2011) 🎓🏅. His dedication to research and education is evident through his active role as a member of Research & Educational Councils (2010-2021) 🏛📖, shaping academic policies and fostering innovation. Additionally, he played a key role in student research, serving as a member of the Student Research Committee at Iran University of Medical Sciences (2010-2011) 🔬👨‍🔬📚, contributing significantly to medical advancements. His commitment to academic excellence and research leadership continues to inspire students and scholars alike. 🌟📖

Research Focus

Dr. Esmaeil Mehraeen is a dedicated expert in health information management, medical informatics, and digital health solutions. 🏥💻 His research spans AI-driven chatbots in healthcare 🤖🏥, telemedicine innovations 📡📞, and self-management systems for HIV patients 🏥📲. He has contributed significantly to epidemiological studies on COVID-19 🦠📊, providing valuable insights into public health responses. His work also delves into ethical considerations in AI healthcare applications ⚖️🤖, health system security 🔐, and data-driven decision-making in public health 📊🌍. Through systematic reviews and meta-analyses 📚🔍, Dr. Mehraeen influences global health informatics research, shaping policies and advancing medical technologies. His interdisciplinary approach fosters innovation, improving healthcare accessibility and efficiency worldwide. 🌍💡👨‍🔬

Publication Top Notes

Predictors of mortality in patients with COVID-19–a systematic review

Late complications of COVID-19; a systematic review of current evidence

Olfactory and gustatory dysfunctions due to the coronavirus disease (COVID‑19): a review of current evidence

The relationship between COVID‐19 viral load and disease severity: A systematic review

The challenges of E‑learning system: Higher educational institutions perspective

Characterization of SARS-CoV-2 different variants and related morbidity and mortality: a systematic review

Effects of COVID-19 prevention procedures on other common infections: a systematic review

Post-synthetic functionalization of the metal-organic framework: Clean synthesis, pollutant removal, and antibacterial activity

Daniel Rudofossi | Medical Hypotheses | Best Researcher Award

Published on 28/03/202528/03/2025 by Research Hypothesis

Daniel Rudofossi | Medical Hypotheses | Best Researcher Award

Dr Daniel Rudofossi, Expert Witness, United States

Dr. Daniel Rudofossi is a distinguished psychologist, researcher, and former NYPD uniform psychologist specializing in trauma, existential analysis, and police/public safety psychology. Holding a Psy.D. in Existential Analysis and a Ph.D. in Psychology from NYU (Summa Cum Laude), he integrates cognitive-behavioral, psychodynamic, and logotherapy approaches in his practice. A Certified Fellow at the Albert Ellis Institute and the Viktor Frankl Institute, Dr. Rudofossi has developed the Eco-Ethological Existential Analysis model for complex PTSD in law enforcement. As Chief Psychologist of the NY & NJ Detective Crime Clinic and an Honorary Police Surgeon, he has significantly contributed to officer wellness. His research and clinical expertise have earned him national recognition, multiple citations for bravery, and invitations to prestigious symposiums. With extensive publications and numerous invited lectures, Dr. Rudofossi continues to shape the field of trauma psychology, ensuring mental resilience for law enforcement professionals. 🚔📖💡

Publication Profile

Scopus

Education

Dr. Daniel Rudofossi is a distinguished psychologist specializing in existential psychology, trauma, and law enforcement psychology. He earned his Psy.D. in Existential Psychology in 2007 and holds a Ph.D. in Psychology from New York University (Summa Cum Laude, 1997) 🎓🏆. His academic journey includes an M.A. in Psychology (4.0 GPA, 1993) and an M.A. in Evolutionary Behavioral Science (3.8 GPA, 1987) from NYU, along with a B.A. in History & Psychology from CUNY (3.76 GPA, 1985). A Certified Fellow in Rational Emotive Behavior Therapy (Albert Ellis Institute, 1996) and certified in Logotherapy (Viktor Frankl Institute), he also holds a Psychoanalytic Psychotherapy Certification (NYPI & Society). Dr. Rudofossi is a Board-Certified Expert in Traumatic Stress (AAETS, 1997) and a graduate of the NYPD Police Academy (1987) 🚔🔬📚. His expertise bridges psychology and law enforcement, making profound contributions to officer wellness and trauma-informed therapeutic approaches.

Experience

Dr. Daniel Rudofossi is a distinguished psychologist with a remarkable career in law enforcement and academia. He served as a Retired Uniform Psychologist in the NYPD Medical Division (1996-2000) and later became the Director of the NYPD Membership Assistance Program, now known as PAPA. As the Chief Psychologist for the NY & NJ Detective Crime Clinic 🕵️‍♂️🧠, he provided critical mental health support to officers. Honored as a Police Surgeon by the NY State Police and Amtrak FOP Lodge NY, he has also been an Adjunct Associate Professor at New York University since 2001 🎓 and an Adjunct Professor at John Jay College of Criminal Justice. A consultant for NYPD Psychological Services 🏛️, he also serves on Saybrook University’s Clinical Psychology Program board. Dr. Rudofossi was a US DOJ DEA EAP Administrative Clinician (2008-2010) and is a respected lecturer and researcher specializing in trauma, PTSD, and law enforcement psychology.

Awards & Honors

Dr. Daniel Rudofossi is a distinguished expert in police trauma and forensic psychology, with a remarkable career blending law enforcement and mental health. A former NYPD officer, he earned six Citations for Bravery in the Line of Duty 🚔🔥 and served as an Honorary Police Surgeon for the NYPD and the NY State Police Investigators Union. A Certified Fellow of the Albert Ellis Institute 🏅, he is also a Diplomate and Board-Certified Expert in Traumatic Stress (AAETS). Dr. Rudofossi has been an invited speaker at prestigious events, including the APA, the Viktor Frankl Institute, and Police Training Symposiums 🎤. His expertise has been nationally televised 📺, focusing on police trauma and suicide prevention. Recognized by the California Commission on Peace Officer Standards & Training (2007), he has contributed to the DSM Treatment & Statistical Manual One 📖🔬, shaping mental health approaches for first responders and trauma survivors.

Research Focus

Dr. Rudofossi specializes in trauma psychology, existential analysis, and police/public safety mental health. His Eco-Ethological Existential Analysis (EEEA) model provides an integrative approach to complex PTSD in law enforcement officers. His research explores coping mechanisms for police stress, disenfranchised loss, and suicide prevention among first responders. He has collaborated with top institutions like APA, Viktor Frankl Institute, and Albert Ellis Institute, contributing to theories on cognitive-behavioral therapy, logotherapy, and psychodynamic approaches in high-risk professions. His work aims to enhance resilience, improve officer wellness programs, and refine trauma intervention techniques in law enforcement.

Publication Top Notes

Conference on Trauma & Loss in Police & Military Combat Veterans (2006)
Eco-Ethological Existential Analysis of Police PTSD – APA Symposium (2006)
Reinfranchising Loss in Police Complex Trauma – APA Symposium (2007)
Police Suicide Prevention & Intervention – CA POST Training (2007)
International Journal of Logotherapy – Trauma in Law Enforcement (2007)
Training Module on Police Suicide Prevention – Viktor Frankl Institute (2007)
Lecture at Albert Ellis Institute – Integrative Approach to PTSD (2007)
Nationally Televised Expert on Police Suicide Prevention – CBS Primetime (2019)

giuseppina malcangi | Medicine and Health Sciences | Best Researcher Award

Published on 19/03/202519/03/2025 by Research Hypothesis

giuseppina malcangi | Medicine and Health Sciences | Best Researcher Award

Dr giuseppina malcangi, University of Bari “Aldo Moro, Italy

Dr. Giuseppina Malcangi is a distinguished researcher in dentistry, specializing in oral surgery, implantology, and orthodontics. She has made significant contributions to regenerative dentistry, nanotechnology applications, and platelet-based therapies. With 128+ indexed publications (h-index: 29, 2397 citations), she has earned global recognition. Her groundbreaking work on herbal medicine for oral health, platelet concentrates in facial rejuvenation, and cytokine interactions in orthodontics highlights her innovative approach. In December 2023, she secured the ASN (Abilitazione Scientifica Nazionale) for Associate Professor, affirming her excellence. Her dedication to advancing dentistry through evidence-based research makes her a strong candidate for the Best Researcher Award.

Publication Profile

Orcid

Education & Specialization

Dr. Giuseppina Malcangi earned her Degree in Dentistry and Dental Prosthetics from the University of Bari, Italy, in 1989. She pursued advanced education with 1st and 2nd level International Master’s in Advanced Oral Surgery and Dental Implantology. Further specializing in Orthodontics, she completed her training at the Interdisciplinary Department of Medicine (D.I.M.), Bari University “Aldo Moro.” Her academic foundation integrates surgical expertise, orthodontic precision, and implantology, ensuring a holistic approach to dental treatments. Her dedication to lifelong learning and specialization in innovative techniques has solidified her reputation as a leading expert in dental research and clinical applications. 🎓🦷🔬

Awards & Honors

Dr. Giuseppina Malcangi earned the ASN Associate Professor Qualification in 2023, a testament to her academic excellence. 🏆 A recognized innovator in dentistry, she holds an international patent for groundbreaking research. 🔬📜 With an impressive portfolio of 128+ indexed journal papers (h-index: 29), four book chapters, and over 50 national journal articles, she has made a lasting impact on dental science. 📚✍️ Her research is widely referenced, accumulating 2,397+ citations as of March 2025. 🔍 As a CLOPD Subject Matter Expert, she is highly regarded for her expertise in oral health sciences. 🏛️ Her commitment to advancing dentistry is evident in her extensive contributions, including high-impact publications, patents, and academic leadership. Through innovation and scholarly excellence, she continues to push the boundaries of dental science, influencing the next generation of researchers and practitioners. 🏅🔬📖

Research Focus

Dr. Malcangi’s research delves into cutting-edge advancements in dentistry, integrating modern technology with traditional practices to enhance patient outcomes. 💡📖🦷 Her work in regenerative dentistry explores the use of stem cells for oral tissue regeneration, offering innovative solutions for dental repair. 🧬🦷 She also pioneers nanotechnology applications, improving the durability and functionality of dental materials. 🏗️🔬 Additionally, she investigates the role of herbal medicine in oral health, developing natural anti-inflammatory treatments for gum diseases. 🌿🩺 Her studies on platelet concentrates and growth factors focus on their applications in facial rejuvenation, contributing to aesthetic and therapeutic advancements. 💉💆‍♀️ Furthermore, her research on cytokine interactions in orthodontics enhances treatment efficiency, optimizing patient care. 🔄😬 By bridging traditional methods with state-of-the-art innovations, Dr. Malcangi continues to shape the future of dentistry, driving progress in both research and clinical practice. 🏅🔬📖

Publication Top Notes

Effectiveness of Herbal Medicines with Anti-Inflammatory, Antimicrobial, and Antioxidant Properties in Improving Oral Health and Treating Gingivitis and Periodontitis: A Systematic Review

The Role of Platelet Concentrates and Growth Factors in Facial Rejuvenation: A Systematic Review with Case Series

The Diagnosis and Management of Infraoccluded Deciduous Molars: A Systematic Review

Stem Cells: Present Understanding and Prospects for Regenerative Dentistry

Nanotechnology and Its Application in Dentistry: A Systematic Review of Recent Advances and Innovations

The Effectiveness of Curcumin in Treating Oral Mucositis Related to Radiation and Chemotherapy: A Systematic Review

The Use of Platelet-Rich Fibrin (PRF) in the Management of Dry Socket: A Systematic Review

Mohamed Hassan | Medicine and Health Sciences | Best Researcher Award

Published on 15/03/202515/03/2025 by Research Hypothesis

Mohamed Hassan | Medicine and Health Sciences | Best Researcher Award

Assist. Prof. Dr Mohamed Hassan, Tulane University School of Medicine, United States

Assist. Prof. Dr. Mohamed Hassan is a distinguished researcher in molecular biology, tumor biology, and virology 🧬. His groundbreaking work focuses on tumor progression, cancer stem cell biology, and innovative therapeutic strategies 🎯. With an extensive portfolio of high-impact publications 📄 and supervised doctoral candidates 🎓, his research significantly contributes to understanding melanoma resistance, non-receptor tyrosine kinases, and immune checkpoint inhibitors 🏥. He has collaborated with leading international institutions, enriching the field with novel discoveries in oncology 🔬. His contributions extend beyond research, fostering the next generation of scientists and improving clinical oncology outcomes 🏥.

Publication Profile

Orcid

Education

Dr. Mohamed Hassan earned his Ph.D. in Molecular Biology 🏅 from the University Hospital of Düsseldorf, Germany (2001), where his research focused on the interference of the Hepatitis C Virus (HCV) core protein with intracellular signal transduction in liver cells 🦠. He holds an M.Sc. in Molecular Biology 📖 from the University of Düsseldorf (1996), with a thesis on identifying and characterizing differentially expressed cDNA libraries in Plasmodium malaria chabaudi immune mice 🧪. His academic journey began with a B.Sc. in Biological Sciences 🏫 from Zagazig University, Egypt, and the University of Düsseldorf (1983). His expertise in cancer biology, virology, and molecular research 📊 has established him as a leading researcher in the field.

Experience

Assist. Prof. Dr. Mohamed Hassan is a dedicated cancer researcher with extensive expertise in tumor progression, oncological drug resistance, and precision medicine 🔬💊. He is currently a Senior Postdoctoral Fellow at the Institut National de la Santé et de la Recherche Médicale, University of Strasbourg, France (2018-2025) 🏥. Previously, he served as a Research Assistant Professor at Tulane University School of Medicine, USA (2016-2018) 🎓, and a Postdoctoral Fellow at the University Hospital of Düsseldorf, Germany (2002-2004). His groundbreaking work focuses on identifying biomarkers and developing targeted therapies to enhance cancer treatment worldwide 🌍🧬.

Research Focus

Assist. Prof. Dr. Mohamed Hassan’s research focuses on tumor progression, cancer stem-like cells, and treatment resistance 🧬. His work delves into melanoma’s resistance to standard therapies 🎯, mechanisms of tumor progression and immune evasion 🏥, and targeting cancer stem-like cells to enhance treatment efficacy 💊. He investigates the role of non-receptor tyrosine kinases in oncogenesis 🔬 and explores immune checkpoint inhibitors and their associated cutaneous adverse effects ⚕️. Additionally, his discovery of antimicrobial peptides holds promise for clinical applications 🦠. His contributions drive novel therapeutic strategies, improving cancer treatment outcomes worldwide 🌍.

CD133-Dependent Activation of Phosphoinositide 3-Kinase /AKT/Mammalian Target of Rapamycin Signaling in Melanoma Progression and Drug Resistance

Mechanisms of Melanoma Progression and Treatment Resistance: Role of Cancer Stem-like Cells

Induction of Antimicrobial Protein S100A15 Expression by Oral Microbial Pathogens Is Toll-like Receptors-Dependent Activation of c-Jun-N-Terminal Kinase (JNK), p38, and NF-κB Pathways